BNET Industries

InforMedix Holdings Inc.

(IFMX) is in the Government Industry

Market Cap:$865.9K
Last Fiscal Year Sales:$305.0K
  • Public
  • US
Dow Jones Description

InforMedix, Inc. has developed, patented and integrated a portable patient monitoring device, hardware, software and networked communications system to enable pharmaceutical firms, medical researchers and physicians to efficiently monitor and manage patients' medication compliance and clinical response. The Med-eMonitor(TM) System leverages InforMedix's patent portfolio of 15 issued and 14 pending patents. InforMedix placed working beta units in pilot sites to validate efficacy and secure endorsements, references and peer-reviewed medical journal articles; and now has a series of academic clinical studies underway with its finished product. InforMedix has established an active Board of Directors and a Scientific Advisory Board comprised of nationally recognized experts in pharmaceutical research, drug trials, business management, and clinical management. InforMedix is now positioned to fully commercialize its technology via direct sales and strategic alliances. On October 4, 2004, InforMedix announced its formation of a strategic alliance with a subsidiary of McKesson Corporation (NYSE: MCK).

Vice President, Pharmacy, Products Leasing
Bruce Kneeland
Number of Employees 5
Contact Information

Georgetowne Park

5880 Hubbard Dr

Rockville, Maryland 20852

3019841566

NAICS Code Administration of Human Resource Programs (except Education, Public Health, and Veterans' Affairs Programs): 923130

News & Analysis

informedix holdings inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Bruce Kneeland Vice President, Pharmacy, Products Leasing
Bruce Morra Director

Organization Position Status
Informedix Holdings, Inc. Vice President, Pharmacy, Products Leasing Current

Dr. Bruce S. Morra has been the President and CEO of SCOLR Pharma, Inc. since January 2009. He has been an independent consultant since February 2000. He was the President of West Drug Delivery Systems, a division of West Pharmaceutical Services, Inc., from April 2003 through December 2004. He served as the President, COO, CFO and board member of Biopore Corporation and Polygenetics, Inc., two related companies developing technology for drug delivery and medical devices for biomedical and industrial applications from 1998 through 2002, then served as Executive Vice President, Chief Business Officer and board member from 2002 to 2004. From 1993 through 2000, he served as President and COO of Flamel Technologies, Inc., a company developing, manufacturing and licensing drug and agrochemical delivery technologies and products. Dr. Morra previously served as director of Unigene from 2001 to 2003. He currently serves as a director for SCOLR Pharma, Inc. and InforMedix Holdings, Inc. Dr. Morra holds a Ph.D. in polymer science and engineering and an M.B.A. from the University of Massachusetts, Amherst and a B.S.E. in chemical engineering from Princeton University.

Organization Position Status
Scolr Pharma, Inc. CEO Current
Scolr Pharma, Inc. Consultant Former
Informedix, Inc. Director, Nominee Current
Unigene Laboratories, Inc. Board of Directors Current
Scolr Pharma, Inc. Board of Directors Current
Informedix, Inc. Board of Directors Current
Informedix Holdings, Inc. Director Current
Biopharm Solutions, Inc Director Current
Flamel Technologies Incorporated President Former
Polygenetics Inc President Former
West Pharmaceutical Services, Inc. President Former
Flamel Technologies Incorporated Coo Former
Polygenetics Inc Coo Former
Progenitor Cell Therapy, LLC Chief Business Officer Former
Flamel Technologies Incorporated Founder Former
Polygenetics Inc Board Member Former
Princeton University Ph.D. In Polymer Science Former
Princeton University B.S.E. Former
advertisement
Click Here
     IFMX $0.00 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 67,456
Shares Outstanding 119.99M
Market Cap 360.0K
Year High 0.08
Year Low 0.001
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement